1. Henderson IC, Harris JR, Kinne DW, Hellman S: Cancer of the breast. Treatment of metastases. In: De Vita VT Jr, Hellman S, Rosenberg SA (eds) Cancer Principles and Practice of Oncology. Lippincott, Philadelphia, 1989, pp 1245?1258
2. Focan C, Andrien JM, Closon MTh, Dicato M, Driesschaert P, Focan-Henrard D, Lemaire M, Lobelle JP, Longree L, Ries F: Dose-response relationship of epirubicin-based first-line chemotherapy for advanced breast cancer: a prospective randomized trial. J Clin Oncol 11: 1253?1263, 1993
3. Floridi A, Paggi MG, Mercante ML, Silvestrini B, Caputo A, De Martino C: Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells. J Natl Cancer Inst 66: 497?499, 1981
4. Floridi A, Paggi MG, D'Atri S, De Martino C, Marcante ML, Silvestrini B, Caputo A: Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells. Cancer Res 41: 4661?4666, 1981
5. Zupi G, Greco C, Laudonio N, Benassi M, Silvestrini B, Caputo A:In vitro andin vivo potentiation by lonidamine of the antitumor effect of adriamycin. Anticancer Res 6: 1245?1250, 1986